Dow Jones Drops More Than 500 Points as Iran Attacks Rattle Markets

2 min read
Dow Jones Drops More Than 500 Points as Iran Attacks Rattle Markets
PrimeXBT Editorial Team
Reviewed by PrimeXBT

Topics in article

The Dow Jones Industrial Average fell more than 500 points on Tuesday after Iran-backed Houthis attacked Saudi Arabia and Iran and the U.S. traded strikes on oil tankers over the weekend. Oil prices climbed off their session highs, Amgen sank on a competitor's failed drug trial, and the S&P 500 and Nasdaq also closed lower.

The Dow industrials dropped more than 500 points, or 1% on Tuesday, marking a rough start to a holiday-shortened week. The sell-off followed an attack on Saudi Arabia by Iran-backed Houthis, which sent oil prices higher before they eased back from their session highs.

Weekend strikes rattle markets

Over the weekend, the U.S. hit three Iranian oil tankers after Iran launched ballistic missiles toward two Navy warships, including an aircraft carrier, according to U.S. Central Command. In retaliation, Iran said it targeted three other oil tankers for using what it claimed was an unauthorized route through the Strait of Hormuz and attacked several U.S.-linked ships, though it remained unclear if any vessels were hit. Operations at certain energy facilities in Saudi Arabia were also halted after the Houthi attacks wounded 73 people.

Oil edges higher, S&P and Nasdaq also fall

West Texas Intermediate crude futures rose less than 1% to about $92.30 a barrel, while Brent crude, the international benchmark, inched up to roughly $97.50 a barrel. The S&P 500 also skidded, dropping 0.3%, with financials and healthcare hit hardest and energy and utilities posting the best gains. The tech-heavy Nasdaq composite was down 0.1% but off its lows, helped by strength in artificial-intelligence stocks.

The 10-year Treasury yield rose 1 basis point to 4.8%. Bitcoin remained down nearly 1% but pared its loss to trade at around $78,700.

Amgen weighs on the Dow

Within the Dow, Amgen sank nearly 10% in heavy volume. The sell-off came after disappointing trial results for an experimental Novartis cardiovascular treatment were seen as a negative indicator for Amgen's own fledgling heart treatment, olpasiran; Novartis itself plummeted 14%. Caterpillar led blue chips with a gain of more than 1%, while Chevron's advance faded to less than 1%.

Source: Investor's Business Daily

Trading involves risk.

Most traded markets

XAU / USD
-0.85% 4,368.98
BRENT
+1.32% 100.306
BTC / USD
-0.96% 78,419.9
EUR / USD
+0.03% 1.16253
USTEC
-0.15% 29,534.76
AAPL
-1.28% 315.37
View all markets

Author

PrimeXBT
Our Editorial Team consists of leading experts with a proven record in the fields of trading, cryptocurrencies, blockchain and finance. We thoroughly research the sources of information in order to provide readers with quality content that serves edu...
Read author’s articles
Alert Triangle Risk Disclaimer
Disclaimer: Some past publications may be outdated. We recommend following our news to stay up to date with the latest information. For any questions, feel free to contact our support team via the chat below.
The content provided here is for informational purposes only. It is not intended as personal investment advice and does not constitute a solicitation or invitation to engage in any financial transactions, investments, or related activities. Past performance is not a reliable indicator of future results.
The financial products offered by the Company are complex and come with a high risk of losing money rapidly due to leverage. These products may not be suitable for all investors. Before engaging, you should consider whether you understand how these leveraged products work and whether you can afford the high risk of losing your money.
The Company does not accept clients from the Restricted Jurisdictions as indicated in our website/ T&C. Some services or products may not be available in your jurisdiction.
The applicable legal entity and its respective products and services depend on the client’s country of residence and the entity with which the client has established a contractual relationship during registration.

Today in markets

Browse Indices News

Register Now

Trading involves risk

Get started in minutes

Our clients love how fast and simple our sign-up is. It takes just a few minutes to get started!

Get Started Get Started
Get started in minutes

Need Help?

Risk Warning:
Trading in leveraged products carries a high level of risk and may not be suitable for all investors.